Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
- 5 July 2011
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 9 (9), 1705-1712
- https://doi.org/10.1111/j.1538-7836.2011.04432.x
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Emergency reversal of antithrombotic treatmentInternal and Emergency Medicine, 2008
- Hemorrhagic Complications of Anticoagulant and Thrombolytic TreatmentChest, 2008
- Antithrombotic and Thrombolytic TherapyChest, 2008
- Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was basedBlood, 2008
- Prevention and Treatment of Major Blood LossNew England Journal of Medicine, 2007
- Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trialThe Lancet Neurology, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinicClinical Therapeutics, 2004
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)The Lancet, 1996
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990